Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ReliaTect + chlorhexidine gluconate is a combination product consisting of ReliaTect (a proprietary or branded component, details unspecified in the available sources) and chlorhexidine gluconate. Chlorhexidine gluconate is a broad-spectrum antiseptic and disinfectant commonly used in oral rinses to reduce bacteria in the mouth, treat gingivitis, and as a topical agent for skin disinfection before surgery or medical procedures. Its mechanism of action involves disruption of microbial cell membranes, leading to cell death. Chlorhexidine is effective against Gram-positive and Gram-negative bacteria, some fungi, and viruses[1][6]. The primary indication for chlorhexidine gluconate is the treatment of gingivitis; it may also be used as an adjunct therapy for periodontitis or as a topical antiseptic[1][3][6]. The specific indications for the combination with ReliaTect are not detailed in public sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ReliaTect + chlorhexidine gluconate.